Clinical Trials Directory

Trials / Unknown

UnknownNCT02937181

Antibiotic Prophylaxis in Open Fractures

Antibiotic Prophylaxis With Ceftaroline for Type II and II Open Fractures: a Phase 4, Open-label, Prospective Clinical Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Olayemi Osiyemi MD · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Prospective look at antibiotic prophylaxis with Ceftaroline in patients with type II and III open fractures

Detailed description

Determine if antibiotic prophylaxis with Ceftaroline in patients with type II and III open fractures is a safe and effective alternative to standard combination therapy

Conditions

Interventions

TypeNameDescription
DRUGCeftarolineIV Ceftaroline will be given for 72 hours

Timeline

Start date
2016-12-01
Primary completion
2018-10-01
Completion
2019-03-01
First posted
2016-10-18
Last updated
2016-10-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02937181. Inclusion in this directory is not an endorsement.